GAGA Share Market News

[hfe_template id='11223'] [ad_1] Shares of the recently listed TBO Tek, which have more than doubled since its listing in May 2024, surged 9.5% on BSE to its new peak at Rs 1,743 after global brokerage firm Goldman Sachs initiated coverages on the stock with a target price of Rs 1,970. The global brokerage firm said that it expects a 22% FY24-27E CAGR, both at the higher end of its global travel coverage, and that they see the company’s India business as indexed to the growth in ‘Affluent India’. TBO’s business model has multiple positive characteristics according to Golman Sachs, as the company is exposed to a large and fragmented TAM with secular growth tailwinds, a strong execution track record, an asset light balance sheet, negative working capital, strong FCF generation, and low competition/regulatory risks. “We expect investor focus and debates to be on the outlook for TBO’s industry, risks of competition from scaled global OTAs,TBO’s international expansion and M...

[hfe_template id='11223'] [ad_1] Shares of CE Info Systems which runs MapmyIndia.com rose 17.6% to Rs 2,354.60 on BSE today after the global brokerage firm Goldman Sachs reportedly initiated coverage on the stock with a target price of Rs 2,800. Goldman Sachs has a ‘buy’ recommendation on CE Info Systems as it foresees an upside potential of over 19% for the stock from its current price of Rs 2,347.45. As per reports, Goldman Sachs believes the company is well-poised to benefit from an early leadership position in fast-growth end-markets. It enjoys over 80% market share in automotive OEM navigation software. Further, the global brokerage firm has projected a 38% revenue CAGR for CE Info Systems from the financial year 2024 to financial year 2027, with a steady EBITDA margin ranging between 38% and 41%. Also read: Consistent winners! 9 multibaggers boast of 25% profit margins for four consecutive quarters CE Info Systems had received an order from Hyundai and Kia Motors i...

[hfe_template id='11223'] [ad_1] Online insurance aggregator PB Fintech's shares climbed 5.2% to Rs 1,360 in Thursday's trade on BSE following a large block deal involving 33 lakh equity shares. Around Rs 428 crore worth of equity shares, representing a 0.73% stake in the company changed hands in this significant transaction. The deal was executed at an average price of Rs 1,297 per share, slightly above the stock's previous close of Rs 1,293.35. The specific buyers and sellers involved in the transaction remain undisclosed. Also Read: TDP-linked stocks soar up to 32% in 2 days after strong election performance Meanwhile, by 12:12 pm, the stock was trading marginally 0.5% lower at Rs 1,287 on BSE. Despite this, the stock has rallied 106% in the last 12 months, compared to a 19% gain in the Sensex.In Q4 FY24, the firm reported a net profit of Rs 60.19 crore, as against a loss of Rs 9.34 crore reported by the company in the year-ago period. The consolidated rev...

[hfe_template id='11223'] [ad_1] Animal healthcare solutions firm Ajooni Biotech on Tuesday opened its rights issue with an aim to raise Rs 43.81 crore from existing shareholders. Ajooni Biotech will offer 8,76,13,721 fully paid-up equity shares of the face value of Rs 2 each at a price of Rs 5 per equity share aggregating to Rs 43.81 crore, the company said in a statement. The issue will close on May 31. Funds raised through the issue will be utilised to finance expenditure towards acquisition of land, site development and civil work, to acquire plant and machinery, part finance working capital requirement and corporate purposes, the company said. The rights entitlement ratio for the proposed issue is fixed at 1:1 (1 equity shares of face value of Rs 2 each for every 1 equity share held) and the record date is May 7. The last date for on-market renunciation of rights entitlements is May 23, 2024. The company's rights issue is offered at Rs 5 per share -- a 20 per...